Biren K. Joshi - Concepedia

Author

Biren K. Joshi

Agricultural Research Service

Also Known As

Biren Joshi, Biren K. Joshi, Joshi, B.K.

Publications

440

Citations

H-Index

Concepts

All Affiliations

Agricultural Research Service University of Iowa National Center for Agricultural Utilization Research GlaxoSmithKline (United States)Research Triangle Park Foundation

About

Biren K. Joshi is an author at Agricultural Research Service specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	188
2	Biochemistry	4	4	103
3	Engineering	2	2	70
4	Natural Sciences	2	2	30
5	Chemical Biology	1	1	20

Biren K. Joshi

Publications

375

Citations

H-Index

Page 1

	Year	Citations
Antifungal Metabolites (Monorden, Monocillin IV, and Cerebrosides) from <i>Humicola fuscoatra</i> Traaen NRRL 22980, a Mycoparasite of <i>Aspergillus flavus</i> Sclerotia Donald T. Wicklow, Biren K. Joshi, William R. Gamble, Applied and Environmental Microbiology	1998	94
Sclerotigenin: A New Antiinsectan Benzodiazepine from the Sclerotia of <i>Penicillium sclerotigenum</i> Biren K. Joshi, James B. Gloer, Donald T. Wicklow, Journal of Natural Products Molecular PharmacologyMedicinal ChemistryNew Antiinsectan BenzodiazepineCh2cl2 ExtractBioassay-guided Isolation	1999	73
Phosphine-Catalyzed Annulation of Thioamides and 2-Alkynoates: A New Synthesis of Thiazolines Bing Liu, Roman Davis, Biren K. Joshi, The Journal of Organic Chemistry 2-Aryl SubstituentsHeterocyclicPhosphine-catalyzed AnnulationOrganic ChemistryNew Synthesis	2002	73
Bioactive Natural Products from a Sclerotium-Colonizing Isolate of <i>Humicola fuscoatra</i> Biren K. Joshi, James B. Gloer, Donald T. Wicklow Journal of Natural Products Antifungal AgentEngineeringBiochemistryBioassay-guided IsolationTriterpenoid Glycoside	2002	50
Recent Trends in Product Development and Regulatory Issues on Impurities in Active Pharmaceutical Ingredient (API) and Drug Products. Part 1: Predicting Degradation Related Impurities and Impurity Considerations for Pharmaceutical Dosage Forms Karen M. Alsante, Kim Huynh‐Ba, Steven W. Baertschi, AAPS PharmSciTech Chemical EngineeringPart 1Active IngredientMedicineDrug Discovery	2013	32
Fungal bis-Naphthopyrones as Inhibitors of Botulinum Neurotoxin Serotype A John H. Cardellina, Virginia Roxas-Duncan, Vicki A. Montgomery, ACS Medicinal Chemistry Letters Microbial ToxinMolecular PharmacologyAntifungal AgentChaetochromin ABiochemistry	2012	23
New Cyclic Peptide and Bisindolyl Benzenoid Metabolites from the Sclerotia of <i>Aspergillus sclerotiorum</i> Authrine C. Whyte, Biren K. Joshi, James B. Gloer, Journal of Natural Products New Cyclic HexapeptideBioorganic ChemistryEngineeringSecondary MetaboliteOrganic Chemistry	2000	20
Development of Large-Scale Routes to Potent GPR119 Receptor Agonists Richard T. Matsuoka, Eric E. Boros, Andrew D. Brown, Organic Process Research & Development Medicinal ChemistryMultikilogram BatchesBiochemistryFunctional SelectivityMedicine	2016	10

Page 1